StockData
Tyra Biosciences, Inc. logo

Tyra Biosciences, Inc. (TYRA) stock

TYRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/30
$20.02+0.26 (+1.32%)

Close on Nov 13, 2026Market cap $1.20BP/E –Yield –

Tyra Biosciences profit margin

Profit margin (net margin) is net income as a percentage of revenue.

No profit margin figures for Tyra Biosciences

Tyra Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Tyra Biosciences figures

See a number that looks wrong?